🎗️ Welcome to the European Cancer Congress – 2026

Arjyopa Healthcare warmly welcomes you to attend the European Cancer Congress – 2026, scheduled for 23rd–24th November, 2026, in London, England. This year’s Congress is organized around the powerful theme: "TOGETHER AGAINST CANCER: SCIENCE, SOLIDARITY, AND SOLUTIONS".

We cordially invite all participants who are passionate about sharing their knowledge and advancing research in the fields of Oncology and Cancer Research.

We are also pleased to share that the European Cancer Congress is a subsidiary of the World Cancer Congress series by Arjyopa, further expanding our mission to foster knowledge exchange and collaboration among cancer researchers, clinicians, and healthcare leaders worldwide. In 2026, we are excited to recreate that vibrant, inspiring environment while bringing new dimensions to the discussion — including the integration of complementary approaches in cancer treatment.

⚠️ Cancer in England: Urgent Realities

In 2023-2025, the UK is projected to see around 420,000 new cancer cases diagnosed each year. This number is projected to rise to around 506,000 cases by 2038-2040. Between 2023-2025 and 2038-2040, the overall incidence rate for all cancers combined is projected to increase by 2%, reaching 625 cases per 100,000 people annually. Specific to females, the increase is projected to be 1%, and for males, it's projected to be 3%.

In 2022, 288,753 new cancer cases were diagnosed in England. The incidence rate was 21% higher in men than in women. More than half of these cases were diagnosed in people over the age of 70. Among adults aged 25 to 59, cancer was more commonly diagnosed in women, while for those aged 65 and older, incidence was approximately 50% higher in men.

Four types of cancer—prostate, breast, lung, and colorectal—accounted for over half of all diagnoses. Cancer remains a leading cause of death, responsible for over a quarter of all annual deaths in England, with 134,802 cancer-related deaths reported in 2021 alone.

🌍 A Global Call to Strengthen, Inspire, and Deliver

We expect to welcome thousands of cancer researchers, healthcare professionals, policy-makers, and industry experts from around the globe to London this November. Together, we will explore new frontiers in science, foster solidarity among the international cancer community, and develop actionable solutions to reduce the burden of cancer worldwide.

🔬 Scientific Focus Areas

The Congress will feature a diverse and comprehensive scientific program covering key areas such as:

• Cancer Biology and Genetics
• Organ-Defined Cancers
• Oncology Sub-specialties
• Radiation and Surgical Oncology
• Stem Cell Therapy and Precision Medicine
• Cancer Epidemiology, Prevention, and Pharmacology
• Cancer Immunology, Vaccines, and Immunotherapy
• Oncology Nursing and Palliative Care
• Complementary and Alternative Medicine
• Lifestyle, Nutrition, and Cancer Survivorship
• Psychological and Social Aspects of Cancer

Join us alongside leading oncologists, scientists, clinicians, pharmaceutical innovators, university researchers, diagnostic experts, and healthcare professionals from every corner of the world.

We look forward to welcoming you to London in November 2026. Together, let’s stand united against cancer—through science, solidarity, and solutions.

🔬 Scientific Tracks

European Cancer Congress – 2026 will cover a wide range of scientific tracks designed to highlight the latest research and developments in oncology:

• 🧬 Cancer Biology & Genetics: Exploring molecular mechanisms, genetic mutations, and tumor microenvironment.
• 🫁 Organ-Defined Cancers: Focused studies on breast, lung, prostate, colorectal, and other organ-specific cancers.
• 🧒 Oncology Sub-specialties: Including pediatric oncology, hematologic cancers, neuro-oncology, and more.
• ☢️ Radiation & Surgical Oncology: Advances in radiotherapy and surgical treatments.
• 🧪 Stem Cell & Precision Medicine: Personalized therapies tailored to individual patient profiles.
• 📊 Cancer Epidemiology & Prevention: Research on risk factors, screening methods, and public health strategies.
• 💉 Immunology & Immunotherapy: Development of vaccines, checkpoint inhibitors, CAR-T therapies, and novel immune treatments.
• 🩺 Oncology Nursing & Palliative Care: Enhancing patient care and quality of life.
• 🌿 Complementary & Alternative Medicine: Integrative approaches and lifestyle modifications.
• 🧠 Psychosocial Aspects of Cancer: Addressing mental health, survivorship, and social support challenges.

Each track will feature expert presentations, discussions, and workshops to foster innovation and collaboration.

📝 Submit Abstract

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days.

Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.

Abstract Guidelines:

• The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
• The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
• Do not use bold type or underline formatting. Italic type is acceptable.
• Text may be in multiple paragraphs.
• Any references should be noted as citations within the text and not as footnotes at the end.